MBI
CPHR

Montrusco Bolton Investments’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Montrusco Bolton Investments’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,267,387
Closed -$8.66M – 87
2016
Q3 		$8.66M Sell
2,267,387
-4,645
-0.2% -$21.2K 0.53% 43
2016
Q2 		$11.8M Sell
2,272,032
-41,029
-2% -$234K 0.75% 31
2016
Q1 		$11.2M Sell
2,313,061
-45,349
-2% -$199K 0.92% 32
2015
Q4 		$11M Buy
2,358,410
+437,803
+23% +$1.89M 0.95% 36
2015
Q3 		$7.09M Buy
1,920,607
+221,881
+13% +$1.54M 0.61% 46
2015
Q2 		$14.5M Buy
1,698,726
+300,434
+21% +$2.99M 1.08% 29
2015
Q1 		$12.7M Buy
+1,398,292
New +$17.6M 0.94% 30

Other funds holding CPHR

GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Montrusco Bolton Investments's CPHR Position: Q4 2016 in Review

Montrusco Bolton Investments sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 2,267,387 shares — an estimated $8.66M sold.

Montrusco Bolton Investments first reported a position in CPHR in Q1 2015 and held it in 7 quarters. The position peaked at $14.5M in Q2 2015. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

  • Montrusco Bolton Investments reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
  • Montrusco Bolton Investments sold 2,267,387 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $8.66M.
  • Montrusco Bolton Investments first reported a position in Cipher Pharmaceuticals Inc. in Q1 2015 and held it in 7 quarters.
  • Montrusco Bolton Investments's Cipher Pharmaceuticals Inc. position peaked at $14.5M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Montrusco Bolton Investments's 13F filing for Q4 2016, filed 19 Jan 2017.